Showing posts sorted by relevance for query DEBT. Sort by date Show all posts
Showing posts sorted by relevance for query DEBT. Sort by date Show all posts

Wednesday, July 21, 2021


Medical Debt in the US, 2009-2020

JAMA. 2021;326(3):250-256. doi:10.1001/jama.2021.8694

 Original Investigation

July 20, 2021
editorial comment icon
Key Points

Question  What is the total amount and distribution of medical debt in collections in the US?

Findings  In this retrospective analysis of credit reports for a nationally representative 10% panel of individuals, an estimated 17.8% of individuals in the US had medical debt in collections in June 2020 (reflecting care provided prior to the COVID-19 pandemic). Medical debt was highest among individuals who lived in the South and in zip codes in the lowest income deciles and became more concentrated in lower-income communities in states that did not expand Medicaid.

Meaning  This study provides an estimate of the amount of medical debt in collections in the US based on consumer credit reports from January 2009 to June 2020, reflecting care delivered prior to the COVID-19 pandemic, and suggests that the amount of medical debt was highest among individuals living in the South and in lower-income communities, although further study is needed regarding debt related to COVID-19.

Abstract

Importance  Medical debt is an increasing concern in the US, yet there is limited understanding of the amount and distribution of medical debt, and its association with health care policies.

Objective  To measure the amount of medical debt nationally and by geographic region and income group and its association with Medicaid expansion under the Affordable Care Act.

Design, Setting, and Participants  Data on medical debt in collections were obtained from a nationally representative 10% panel of consumer credit reports between January 2009 and June 2020 (reflecting care provided prior to the COVID-19 pandemic). Income data were obtained from the 2014-2018 American Community Survey. The sample consisted of 4.1 billion person-month observations (nearly 40 million unique individuals). These data were used to estimate the amount of medical debt (nationally and by geographic region and zip code income decile) and to examine the association between Medicaid expansion and medical debt (overall and by income group).

Exposures  Geographic region (US Census region), income group (zip code income decile), and state Medicaid expansion status.

Main Outcomes and Measures  The stock (all unpaid debt listed on credit reports) and flow (new debt listed on credit reports during the preceding 12 months) of medical debt in collections that can be collected on by debt collectors.

Results  In June 2020, an estimated 17.8% of individuals had medical debt (13.0% accrued debt during the prior year), and the mean amount was $429 ($311 accrued during the prior year). The mean stock of medical debt was highest in the South and lowest in the Northeast ($616 vs $167; difference, $448 [95% CI, $435-$462]) and higher in poor than in rich zip code income deciles ($677 vs $126; difference, $551 [95% CI, $520-$581]). Between 2013 and 2020, the states that expanded Medicaid in 2014 experienced a decline in the mean flow of medical debt that was 34.0 percentage points (95% CI, 18.5-49.4 percentage points) greater (from $330 to $175) than the states that did not expand Medicaid (from $613 to $550). In the expansion states, the gap in the mean flow of medical debt between the lowest and highest zip code income deciles decreased by $145 (95% CI, $95-$194) while the gap increased by $218 (95% CI, $163-$273) in the nonexpansion states.

Conclusions and Relevance  This study provides an estimate of the amount of medical debt in collections in the US based on consumer credit reports from January 2009 to June 2020, reflecting care delivered prior to the COVID-19 pandemic, and suggests that the amount of medical debt was highest among individuals living in the South and in lower-income communities. However, further study is needed regarding debt related to COVID-19.

Introduction

Due to rising health care prices,1,2 increased cost sharing,3 and 26.1 million individuals without insurance in 2019,4 the US health care system leaves patients with high out-of-pocket costs.1,5 If these medical bills are unpaid, the outstanding amount can be classified as medical debt and sent to debt collectors.

Medical debt is associated with reduced health care use.6 Personal debt, broadly defined, is associated with worse mental health7,8 and a deterioration of personal finances.9 Despite widespread concern, there is only limited evidence on recent trends in medical debt, its distribution across individuals, and how health policy has affected the distribution of medical debt. To our knowledge, no studies have estimated the total amount of medical debt. Moreover, even though recent studies have estimated the effect of the Affordable Care Act (ACA) coverage expansion on individual consumer debt,9,10 no study has investigated its association with differences across geographic areas and socioeconomic groups.

To study these issues, a nationally representative person-level 10% sample of all consumer credit reports observed monthly from 2009 through 2020 was used to (1) document the scale and prevalence of medical debt nationally, (2) characterize differences in medical debt across geographic regions and income groups, and (3) examine the association between ACA Medicaid expansion and the distribution of medical debt across individuals.

Methods
Data Sources and Study Population

We measured unpaid medical debt in collections using a nationally representative, randomly selected 10% panel of all individuals with credit reports maintained by TransUnion, which is 1 of the 3 nationwide credit reporting agencies. The data were deidentified and included birth dates, zip codes, loan repayment history, public records, and medical and nonmedical accounts in collections. Because the data were not specifically collected for this study and were deidentified, the study was not considered human subjects research.11

Persons in the credit panel were monitored each month from January 2009 through June 2020. We excluded persons with a missing age or zip code, those residing outside the 50 states or the District of Columbia, and those with empty reports (defined as reports with no credit records of any kind). We also replicated the analyses using a sample that retains these empty accounts (eMethods, eFigures 1-4, and eTable 1 in the Supplement). Additional details on the sample construction appear in the eMethods in the Supplement.

Medical debt is reported to TransUnion by third-party debt collectors. It is typically reported at least 180 days after the bill was incurred and must be removed from the credit report after 7 years.12 For each medical debt item, we observed the date when the bill became delinquent, its current balance, and whether the debt was in dispute or had been closed. We excluded medical debts that had been paid, were in dispute, or that had been closed. Dollar amounts were adjusted for inflation to June 2020 using the consumer price index for all urban consumers and censored at the 99.99th percentile to reduce the influence of extreme outliers.

Exposures

We documented regional patterns by reporting measures of medical debt by US Census region (a list of states by US Census region appears in eTable 2 in the Supplement) and by constructing county-level maps of mean medical debt.

To analyze differences in medical debt by income, we computed the mean stock (all unpaid debt listed on credit reports) of medical debt by zip code income decile. We assigned each zip code to a decile using per-capita income estimates from the 5-year American Community Survey (2014-2018), weighting each zip code by its population in the survey. We then calculated the measures of medical debt separately for each decile group.

To analyze the association between medical debt and Medicaid expansion, we assigned states to 1 of 3 groups: (1) states that expanded Medicaid in 2014 (28 states), (2) states that expanded Medicaid after 2014 (11 states); and (3) states that did not expand Medicaid (12 states). Except for a small number of states with limited early expansion, Medicaid expansion was first implemented in 2014.13 A list of states by Medicaid expansion status appears in eTable 3 in the Supplement.

Outcomes

The main outcomes were the stock (defined above) and flow (new debt listed on credit reports during the preceding 12 months) of medical debt. The stock is the preferred measure of total medical debt.

Because debt in collections can remain on credit reports for 7 years, it can take up to 7 years for changes in policy to be fully reflected in the stock of medical debt. To analyze the association between Medicaid expansion under the ACA and medical debt, we constructed a measure of the flow of medical debt. The flow measure is unaffected by outflows (arising from repayment or because a collector stops reporting on the debt) and thus can be used to assess the sensitivity of the estimates to the potential differences in outflows across industries, regions, or income groups.

To maintain a consistent reference point, we computed statistics as of June for each year. Because of the 180-day delay in credit reporting, statistics from June 2020 (the most recent month in the study sample) did not reflect medical care received by patients in 2020 and were unaffected by the COVID-19 pandemic.

For comparison, we constructed analogous measures of nonmedical debt in collections. Nonmedical debt combines all other sources of debt in collections, including credit cards, personal loans, utilities, and phone bills. As with medical debt, these amounts represent bills that are unpaid and can be collected on by debt collectors.

Statistical Analysis

To analyze the association between medical debt and Medicaid expansion, we conducted a difference-in-differences analysis that compared percentage changes over time in the flow of medical debt in states that expanded Medicaid vs the percentage changes over time in states that did not expand Medicaid. Specifically, we normalized the level of medical debt for each group of states to 1 in 2013 (the year before Medicaid expansion in the intervention group) and calculated the percentage change relative to this year. This normalization adjusts for any cross-sectional differences among groups of states that would otherwise confound the estimates. The trends without this normalization appear in eFigure 5 in the Supplement.

In the sensitivity analysis, we estimated the association between medical debt and Medicaid expansion with linear regressions of the percentage change in the mean flow of medical debt between 2013 and 2020 on indicators for the Medicaid expansion groups and a constant, controlling for state-level changes in economic factors (unemployment rate, the percentage of the population aged ≥65 years, the percentage of individuals aged ≥25 years and with a bachelor’s degree or higher, and median income), the state-level share of beds at for-profit hospitals, and state-level policies (debt collection laws and surprise out-of-network billing laws). For some of the control variables, data for 2020 were not available, so we used data from 2013 and 2019. Additional details appear in eTables 4-5 in the Supplement.

To assess whether the association between Medicaid expansion and medical debt reflected confounding factors (such as differential economic trends), we conducted the analyses separately using nonmedical debt as the outcome. To analyze the relationship between Medicaid expansion and income-based differences in medical debt, we estimated the mean flow of medical debt between 2009 and 2020 by zip code income decile separately for Medicaid expansion and nonexpansion states. To maintain consistent zip code income deciles across Medicaid expansion and nonexpansion states, we continued to assign zip codes to income deciles based on their population-weighted rank in the national distribution.

The raw data were extracted and collapsed to the zip code year using Spark SQL version 2.2.1 (Apache Software Foundation) via Python version 3.6.3 (Python Software Foundation). The processed data were analyzed using Stata/MP version 16.0 (StataCorp). The 95% CIs for the national, regional, and zip code income decile estimates were based on standard errors constructed using the zip code year data. Tests of statistical significance were based on 2-sided tests with a significance threshold of .05. Because of the potential for type I error due to multiple comparisons, the findings for the secondary analyses should be interpreted as exploratory.

Results
National Trends in the Mean Stock and Flow of Medical Debt

The 10% panel of consumer credit reports held 4.1 billion person-month observations and nearly 40 million (n = 39 788 671) unique individuals. The mean stock of medical debt increased from $750 in 2009 to a peak of $827 in 2010 (difference, $76 [95% CI, $61-$92]) before decreasing to $429 in 2020 (difference, $397 [95% CI, $384-$411]) (Figure 1A). During this period, medical debt overtook nonmedical debt as the largest source of debt in collections. In 2009, mean medical debt was $119 (95% CI, $112-$127) less than nonmedical debt, whereas in 2020 medical debt exceeded nonmedical debt by $39 (95% CI, $34-$43). Numerical values for each year appear in eTable 6 in the Supplement.

The mean flow of medical debt also increased from $332 in 2009 to a peak of $427 in 2013 (difference, $95 [95% CI, $87-$103]) before decreasing to $311 in 2020 (difference, $116 [95% CI, $108-$124]) (Figure 1B). Similar to the stock, the flow of medical debt overtook nonmedical debt as the largest source of new debt in collections during this period. In 2009, medical debt was $120 (95% CI, $116-$124) less than nonmedical debt, whereas in 2020 medical debt exceeded nonmedical debt by $78 (95% CI, $75-$82).

Summary statistics on the amount of US debt in 2020 and by US Census region appear in the Table. At the national level, 17.8% of persons with a credit report had medical debt in collections and 13.0% accrued medical debt during the prior year. Conditional on having medical debt, the mean stock was $2424 and the mean flow was $2396.

Regional and Income-Based Differences in Medical Debt

The mean stock of medical debt by county in 2020 appears in Figure 2A (the analogous map for the mean flow of medical debt by county appears in eFigure 6A in the Supplement). Medical debt was concentrated in the South as well as in some counties in the West. Of the 4 US Census regions, the South had the highest amount of medical debt, with medical debt held by 23.8% of persons and a mean stock of $616 (95% CI, $608-$623). The Northeast had the lowest amount of medical debt, with medical debt held by 10.8% of persons and a mean stock of $167 (95% CI, $163-$172). The difference between the South and Northeast was $448 (95% CI, $435-$462).

The mean stock of medical debt by zip code income decile appears in Figure 2B (the numerical values appear in eTable 7 and the statistics for the mean flow of medical debt by zip code income decile appear in eFigure 6B in the Supplement). The mean stock of medical debt was $677 (95% CI, $662-$692) in the 1st (lowest) zip code income decile, $473 (95% CI, $462-$484) in the 5th zip code income decile, and $126 (95% CI, $121-$131) in the 10th (highest) zip code income decile. The difference between the lowest and highest zip code deciles was $551 (95% CI, $520-$581).

Medicaid Expansion Under the ACA and Accrual of Medical Debt

The flow of medical debt between 2009 and 2020 by Medicaid expansion status appears in Figure 3A, with the levels for each group of states normalized to 1 in 2013. Between 2013 and 2020, the states that expanded Medicaid in 2014 experienced a decline in the mean flow of medical debt that was 34.0 percentage points (95% CI, 18.5-49.4 percentage points) greater (from $330 to $175) than the states that did not expand Medicaid (from $613 to $550). States that expanded Medicaid after 2014 experienced a decline in the mean flow of medical debt that was 20.4 percentage points (95% CI, 1.2-39.6 percentage points) greater (from $401 to $288) than the states that did not expand Medicaid (from $613 to $550). The numerical values appear in eTable 8 in the Supplement. The regression tables that underlie these estimates show consistent results from the specifications that control for economic and policy factors (eTables 4-5 in the Supplement).

The analogous plots for nonmedical debt appear in Figure 3B and the estimates from the regression specifications appear in eTable 9 in the Supplement. For nonmedical debt, there were no significant differences across the groups. Expansion states experienced a decline in the mean flow of nonmedical debt of 45.4% (95% CI, 38.8%-52.1%) from $388 to $206; late expansion states experienced a decline of 37.7% (95% CI, 33.0%-42.4%) from $337 to $212; and nonexpansion states experienced a decline of 40.9% (95% CI, 35.3%-46.6%) from $488 to $287.

Medicaid Expansion Under the ACA and Income-Based Differences in the Accrual of Medical Debt

The flow of medical debt in 2009 and 2020 by zip code income decile appears separately for states that expanded Medicaid (Figure 4A) and for states that did not expand Medicaid (Figure 4B). The states that expanded Medicaid after 2014 are not shown.

Within states that expanded Medicaid (Figure 4A), all zip code income deciles experienced reductions in medical debt from 2009 to 2020, with larger reductions in the lower zip code income deciles. In the lowest zip code income decile, the mean flow of medical debt decreased by $180 (95% CI, $131-$229) from $458 to $278. In the highest zip code income decile, the mean flow of medical debt decreased by $35 (95% CI, $27-$44) from $95 to $60. The gap in the mean flow of medical debt between the lowest and highest zip code income deciles decreased by $145 (95% CI, $95-$194) from $363 to $218.

Within states that did not expand Medicaid (Figure 4B), most zip code income deciles experienced an increase in medical debt from 2009 to 2020; there were greater increases in the lowest zip code income deciles. In the lowest zip code income decile, the mean flow of medical debt increased by $206 (95% CI, $156-$256) from $630 to $836. In the highest zip code income decile, the mean flow of medical debt decreased by $12 (95% CI, $10-$35) from $196 to $184. The gap in the mean flow of medical debt between the lowest and highest zip code income deciles increased by $218 (95% CI, $163-$273) from $434 to $652.

Discussion

In a retrospective analysis of consumer credit reports, the mean amount of medical debt was high, and it was greater among individuals who lived in the South and in zip codes in the lowest income deciles. Medicaid expansion under the ACA was associated with reduced medical debt overall, and with reduced gaps in the amount of medical debt between low-income and high-income communities.

During the last decade, medical debt has become the largest source of debt in collections. The reductions in nonmedical debt in collections between 2009 and 2020 occurred simultaneously with the economic recovery from the Great Recession, consistent with the well-documented association between unemployment and loan delinquency.14 In contrast, total medical debt in collections decreased by a more modest amount. As a result, as of June 2020 individuals had $39 more in mean medical debt in collections than they had in mean debt in collections from all other sources combined ($429 vs $390), including credit cards, utilities, and phone bills.

The randomized sampling design can be used to extrapolate to the total amount of medical debt in collections reported to TransUnion. Multiplying mean medical debt of $429 in June 2020 by the sample size and a factor of 10 (because the sample is a 10% random sample of TransUnion credit reports) implies the existence of $140 billion in total medical debt. Even though this extrapolation can estimate total medical debt in collections listed on TransUnion credit reports, the limitations of the data preclude extrapolation to total medical debt in the US.

The analysis shows that Medicaid expansion was associated with reductions in medical debt in collections. Although the study design does not allow for causal interpretation, the absence of a meaningful association between Medicaid expansion and changes in nonmedical debt, and the stability of the estimates, controlling for economic and policy factors, reduce concerns about possible confounders.15 These estimates are consistent with studies that have used experimental methods to establish a causal link between Medicaid coverage and reductions in medical debt.16

Many of the states with the highest pre-ACA levels of medical debt did not expand Medicaid and subsequently did not experience substantial reductions in medical debt. Specifically, 8 of the 12 states that did not expand Medicaid are in the South, the region with the highest pre-ACA levels of medical debt (eTable 3 in the Supplement). The mean medical debt decreased by 44.0% between 2013 and 2020 in states that immediately expanded Medicaid, but it only decreased by 10.0% in the nonexpansion states, exacerbating preexisting regional differences.

Within the states that expanded Medicaid, there were reductions in income-based differences. In states that expanded Medicaid, the gap in the flow of medical debt between those living in in the lowest and highest zip code income deciles decreased over the 2009 to 2020 period, whereas the gap in the flow of medical debt increased in states that did not expand Medicaid.

Taken together, the results on income and regional differences indicate that individuals in the lowest zip code income deciles in states that did not expand Medicaid had the highest levels of medical debt in the country at the start of the study period and also experienced the largest subsequent increases in mean medical debt. For instance, the lowest zip code income decile in states that did not expand Medicaid had both the highest level of medical debt in 2009 and the largest increase over the 2009 to 2020 period.

Limitations

This study has several limitations. First, the measures of medical debt were derived from debts that were reported to TransUnion, which may not be identical to the debts reported to other credit bureaus.17

Second, the data did not allow for the measurement of medical debts that are not reported to credit bureaus, which may differ by industry, region, or income group. Third, the data may have included reports for persons who had emigrated or multiple reports for a person that were not linked.

Fourth, the stocks of debt in collection (but not the flows) were influenced by outflows from credit reports; outflows may differ by industry, region, and income group and are difficult to interpret. Fifth, the measures of medical debt did not capture medical expenses that were paid with a credit card or other financial products.

Sixth, even though the study examined the association between medical debt and income at the zip code level, it was not possible to study this (or other associations) at the individual level. Seventh, the regression specifications that examined the association between Medicaid expansion and medical debt were unable to control for individual-level factors or all potentially relevant time-varying state-level confounders.

Eighth, because medical debt is reported to credit bureaus after a 180-day delay, the measures of medical debt in 2020 did not capture debt incurred during the COVID-19 pandemic (or any debt from care provided in 2020).

Conclusions

This study provides an estimate of the amount of medical debt in collections in the US based on consumer credit reports from January 2009 to June 2020, reflecting care delivered prior to the COVID-19 pandemic, and suggests that the amount of medical debt was highest among individuals living in the South and in lower-income communities. However, further study is needed regarding debt related to COVID-19.

Back to top
Article Information

Corresponding Author: Neale Mahoney, PhD, Stanford University, 579 Jane Stanford Way, Stanford, CA 94305 (nmahoney@stanford.edu).

Accepted for Publication: May 13, 2021.

Author Contributions: Dr Mahoney had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: All authors.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: All authors.

Administrative, technical, or material support: Yin.

Supervision: Mahoney, Yin.

Conflict of Interest Disclosures: None reported.

Funder/Support: Dr Mahoney was supported by internal research funds from the University of Chicago (where he was a faculty member through June 2020) and Stanford University (where he has been a faculty member since July 2020). Dr Wong was supported by grant T32-AG000186 from the National Institute on Aging. The credit data used in this study were provided by TransUnion, a global information solutions company, through a relationship with the Kilts Center for Marketing at the University of Chicago Booth School of Business.

Role of the Funder/Sponsor: No funder/sponsor had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; and decision to submit the manuscript for publication. TransUnion had the right to review the research before dissemination to ensure it accurately describes TransUnion data, does not disclose confidential information, and does not contain material it deems to be misleading or false regarding TransUnion, TransUnion’s partners, affiliates or customer base, or the consumer lending industry.

Additional Contributions: We thank Xuyang Xia, BA (research assistant at Stanford University), for making substantial contributions to the data analysis and who was compensated.

References
1.
Health Care Cost Institute. 2017 health care cost and utilization report. Accessed March 14, 2020. https://www.healthcostinstitute.org/images/pdfs/HCCI_2017_%20Health_%20Care_Cost_and_Utilization_Report_02.12.19.pdf
2.
Dieleman  JL, Squires  E, Bui  AL,  et al.  Factors associated with increases in US health care spending, 1996-2013.   JAMA. 2017;318(17):1668-1678.
ArticlePubMedGoogle ScholarCrossref
3.
Kaiser Family Foundation. 2018 employer health benefits survey. Accessed March 14, 2020. https://www.kff.org/report-section/2018-employer-health-benefits-survey-section-7-employee-cost-sharing/attachment/figure-7-14/
4.
Keisler-Starkey  K, Bunch  LN.  Health insurance coverage in the United States: 2019.  Accessed March 14, 2020. https://www.census.gov/content/dam/Census/library/publications/2020/demo/p60-271.pdf
5.
Centers for Medicare & Medicaid Services. National health expenditure fact sheet. Accessed March 14, 2020. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet
6.
Kalousova  L, Burgard  SA.  Debt and foregone medical care.   J Health Soc Behav. 2013;54(2):204-220.PubMedGoogle ScholarCrossref
7.
Jenkins  R, Bhugra  D, Bebbington  P,  et al.  Debt, income and mental disorder in the general population.   Psychol Med. 2008;38(10):1485-1493.PubMedGoogle ScholarCrossref
8.
Meltzer  H, Bebbington  P, Brugha  T,  et al.  The relationship between personal debt and specific common mental disorders.   Eur J Public Health. 2013;23(1):108-113.PubMedGoogle ScholarCrossref
9.
Brevoort  K, Grodzicki  D, Hackmann  MB.  The credit consequences of unpaid medical bills.   J Public Econ. 2020;187:104203. doi:10.1016/j.jpubeco.2020.104203Google Scholar
10.
Hu  L, Kaestner  R, Mazumder  B, Miller  S, Wong  A.  The effect of the Affordable Care Act Medicaid expansions on financial wellbeing.   J Public Econ. 2018;163:99-112.PubMedGoogle ScholarCrossref
11.
Protection of human subjects, 45 CFR Part 690. Accessed June 15, 2020. https://www.govinfo.gov/app/details/CFR-2012-title45-vol3/CFR-2012-title45-vol3-part690
12.
Requirements relating to information contained in consumer reports, 15 US Code §1681c. Accessed June 15, 2020. https://www.govinfo.gov/app/details/USCODE-2010-title15/USCODE-2010-title15-chap41-subchapIII-sec1681c
13.
Sommers  BD, Kenney  GM, Epstein  AM.  New evidence on the Affordable Care Act.   Health Aff (Millwood). 2014;33(1):78-87.PubMedGoogle ScholarCrossref
14.
Gerardi  K, Herkenhoff  KF, Ohanian  LE, Willen  PS.  Can’t pay or won’t pay?   Rev Financ Stud. 2018;31(3):1098-1131. doi:10.1093/rfs/hhx115Google ScholarCrossref
15.
Oster  E.  Unobservable selection and coefficient stability.   JBES. 2019;37(2):187-204. doi:10.1080/07350015.2016.1227711Google Scholar
16.
Finkelstein  A, Taubman  S, Wright  B,  et al.  The Oregon health insurance experiment.   Q J Econ. 2012;127(3):1057-1106.PubMedGoogle ScholarCrossref
17.
Federal Trade Commission. Report to Congress under section 319 of the Fair and Accurate Credit Transactions Act of 2003. Accessed March 14, 2020. https://www.ftc.gov/sites/default/files/documents/reports/section-319-fair-and-accurate-credit-transactions-act-2003-fifth-interim-federal-trade-commission/130211factareport.pdf